SEARCH

SEARCH BY CITATION

Summary

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

Campylobacter fetus infection is a substantial problem in herds of domestic cattle worldwide and a rising threat in human disease. Application of comparative and functional genomics approaches will be essential to understand the molecular basis of this pathogen's interactions with various hosts. Here we report recent progress in genome analyses of C. fetus ssp. fetus and C. fetus ssp. venerealis, and the development of molecular tools to determine the genetic basis of niche-specific adaptations. Campylobacter research has been strengthened by the rapid advancements in imaging technology occurring throughout microbiology. To move forward in understanding the mechanisms underlying C. fetus virulence, current efforts focus on developing suitable in vitro models to reflect host- and tissue-specific aspects of infection.


Introduction

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

Pathogenesis of Campylobacter fetus

Campylobacter fetus is traditionally recognized as a significant pathogen of livestock. Its occurrence as an opportunistic human pathogen is uncommon, yet this is believed to be underestimated and is apparently increasing (Blaser, 1998; Blaser et al., 2008). Campylobacter fetus belongs to the group of ε-proteobacteria and is highly adapted to mucosal surfaces (Hu and Kopecko, 2000). Two subspecies of C. fetus have been designated, C. fetus ssp. fetus and C. fetus ssp. venerealis. Nearly all C. fetus infections in humans are systemic and arise due to C. fetus ssp. fetus. This subspecies is the predominant Campylobacter species isolated from human blood (Blaser, 1998) and is considered to be an emerging pathogen placing infants, elderly, immunocompromised and debilitated persons at risk (Skirrow and Blaser, 2000; Thompson and Blaser, 2000). Both C. fetus ssp. fetus and C. fetus ssp. venerealis cause disease in cattle. The subspecies show distinct niche preferences, yet these are not strictly exclusive. In ruminants C. fetus ssp. venerealis colonizes the genital tract while C. fetus ssp. fetus is largely confined to the gut. However, both subspecies can be recovered from the genital tract and are a major cause of abortion and infertility causing substantial losses in bovine, ovine and caprine herds worldwide. Despite this pathogen's global economic and rising clinical significance, the molecular mechanisms underlying infection of its human and animal hosts remain largely unknown. Until very recently, the absence of genetic tools to manipulate C. fetus (Kienesberger et al., 2007) and the lack of tractable infection models to investigate the molecular basis of host–pathogen interactions has slowed research with this organism. In this review we describe recent progress in molecular approaches applicable in the study of C. fetus.

Genome analyses and the mobile gene pool

The first complete genome sequence of a Campylobacter species, the C. jejuni clinical isolate NCTC 11168, was published in 2000 (Parkhill et al., 2000). Up to now 11 complete and 24 unfinished genome sequences have been deposited in the public databases (Parkhill et al., 2000; Fouts et al., 2005; Pearson et al., 2007; Poly et al., 2007; Miller, 2008). Similar to other campylobacters the genome size of C. fetus is rather small (∼1.8 Mb). Genome sizing by pulsed field gel electrophoresis revealed size variation between strains (Salama et al., 1992). Multilocus sequence typing (MLST) is a procedure for characterizing isolates of bacterial species using the sequences of internal fragments of genes (Maiden et al., 1998; http://pubmlst.org/). Typically, seven housekeeping genes are used in this analysis. The profile of allele sequences for a given bacterial isolate defines the sequence type. The MLST analysis has shown a clonal population structure within C. fetus, wherein C. fetus ssp. venerealis represents a bovine clone (van Bergen et al., 2005; Dingle et al., 2010). This is in contrast to other Campylobacter species, which show extensive genetic variation (e.g. C. jejuni). This variability is thought to continuously improve the capacity to colonize and persist in various habitats (de Boer et al., 2002; Wiesner et al., 2003).

Current efforts to obtain complete genome sequences of representatives of both C. fetus subspecies are expected to bring rapid advances. The complete sequence of C. fetus ssp. fetus 82-40 was finished in 2006, revealing that 90% of the genome constitutes coding sequence (GenBank Accession number NC_008599). A draft genome sequence of C. fetus ssp. venerealis 84-112 has just become available (EBI Project ID: 42511). Access to both genome sequences provides the resources for detailed analysis of C. fetus physiology as well as subspecies-specific adaptations, and will stimulate efforts to identify mechanisms contributing to pathogen–host interactions and virulence. The comparative approach will certainly shed light on the niche preferences displayed by the C. fetus subspecies. In addition, the C. fetus sequences are expected to open new perspectives for subtyping methods as well as for improving or establishing novel diagnostic approaches for this emerging pathogen.

The process of horizontal gene transfer (HGT) in bacteria drives genetic diversity and evolution providing also a basis for variation in the virulence repertoire as well as resistance to antibiotics and host defences (Hacker et al., 1997; Gogarten et al., 2002; Koonin and Wolf, 2008; Boto, 2010; Juhas et al., 2009). DNA acquired by these mechanisms apparently accounts for 5–6% of the genome of certain campylobacters (Eppinger et al., 2004). Comparative genomic analysis is expected to reveal further species- or strain-variation due to evolutionary gene mobility. An initial comparison of the C. fetus genomes confirmed that C. fetus ssp. venerealis DNA presumably acquired by horizontal mechanisms indeed represents the major difference between the two subspecies.

An important technique in functional and comparative genomics is representational difference analysis (RDA). The methodology was developed to compare the differences in complex genomes as well as to obtain clones of those differentiating genes (Lisitsyn and Wigler, 1993). Before the availability of the C. fetus genome sequences RDA was applied to reveal genes uniquely or predominantly present in just one C. fetus subspecies (Gorkiewicz et al., 2010). Consistent with the hypothesis that distinguishing physiological and virulence properties of the subspecies relate to the existence of different sets of genes, homology searches revealed that multiple genes uniquely or predominantly associated with a given subspecies indeed encode virulence-related attributes ranging from motility to lipopolysaccharide production to bacterial secretion. A large genomic island unique to C. fetus ssp. venerealis was shown to encode a conjugation-related type IVa macromolecular secretion system (T4SS) (for system classifications see Christie and Vogel, 2000). Mutational analyses confirmed that the secretion machinery is involved in the ability of C. fetus ssp. venerealis to infect and induce cytopathic effects in cultured human epithelial and placenta cells (see below; Gorkiewicz et al., 2010). Moreover, the T4SS was shown to be active in intra- and interspecies conjugative mobilization of plasmid DNA (S. Kienesberger, G. Gorkiewicz, A. Fauster and E.L. Zechner, unpublished) derived from the cryptic C. coli plasmid pIP1455 (Lambert et al., 1985). This finding marks the first experimental demonstration of HGT in C. fetus. Evidence for natural transformation is still lacking (Blaser et al., 2008). Characterization of gene transfer by conjugation will certainly lead to the application of tools for DNA delivery among campylobacters (S. Kienesberger, G. Gorkiewicz, A. Fauster and E.L. Zechner, unpublished).

Knowledge of gene mobilization via conjugative mechanisms is also important in assessing the contribution of HGT to the evolution of the C. fetus subspecies and campylobacters generally. Conversely analysis of the genomes will provide insights to the presence and activities of clustered, regularly interspaced, short palindromic repeat (CRISPR) loci, which have been identified in a variety of different bacteria including campylobacters (Miller, 2008). These hypervariable genetic loci capture incoming DNA acquired by multiple routes of HGT and provide sequence-directed immunity to invasive phage and plasmids (Marraffini and Sontheimer, 2008; Horvath and Barrangou, 2010). The CRISPR interference thus limits HGT. It is reasonable to predict that future studies will demonstrate a continued proficiency for mobility for some of the horizontally acquired elements in C. fetus as well as direct evidence for CRISPR-directed counteraction of lateral gene spread.

Molecular genetics

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

Genetic manipulation of C. fetus is becoming easier as new molecular tools are developed. The available E. coli– Campylobacter shuttle vectors suitable for applications in C. fetus are all derived from small cryptic plasmids endogenous to campylobacter (Kienesberger et al., 2007). Figure 1 illustrates a selection of shuttle vectors and their salient features. Currently three distinct replicons are known to be functional in C. fetus, namely derivatives of the C. coli plasmid pIP1455 (Lambert et al., 1985), a cryptic C. hyointestinalis plasmid present in strain 45104 (Waterman et al., 1993), and the C. fetus ssp. venerealis plasmid pCFV108 (Kienesberger et al., 2007). The pIP1455 derivatives are universally used for C. jejuni and C. coli applications. The pCFV108 replicon is restricted to C. fetus. A 4.5 kb fragment of pIP1455 DNA is required for vector derivatives to be efficiently replicated in campylobacter. By contrast, the minimal replicon of pCFV108 is comprised of only 82 bp. These vector lineages are stably maintained in all the C. fetus strains we have tested thus far. Importantly, both replicons remain stable in the absence of antibiotic selection. That property is advantageous for in vitro experiments involving co-cultivation of plasmid-carrying bacteria and cultured mammalian cells over days (> 6 days), or in reviving frozen stocks of plasmid-carrying C. fetus on blood agar without selection. It is also significant that the pIP1455 and the pCFV108 vector lineages are compatible for stable maintenance in the same host cell, thereby diversifying options for expression of molecular reporters and genes of interest.

image

Figure 1. Selected E. coli-C. fetus shuttle vectors based either on the pIP1455 or on the pCFV108 replication origin (oriV). Functional modules are identified as follows: mobilization from E. coli to Campylobacter (nicIncP); replication in E. coli (oriVpBR322, pBluescriptIIKS(-)), Campylobacter (oriVpIP1455), or C. fetus (oriVpCFV108); antibiotic selection for chloramphenicol (cat), kanamycin (aphA-3), tetracycline (tetO); promoters for gene expression in E. coli PCc (C. coli promoter) and C. fetus (PsapA-Cfv, P: gatC, rpsJ, glnA, gltA, gyrA). Restriction enzymes for cloning are indicated. Abbreviations: Sa, SacI; N, NotI; X, XbaI; B, BamHI; S; SmaI; P, PstI; E, EcoRI; EcV, EcoRV.

Download figure to PowerPoint

Campylobacter fetus acquires plasmid DNA efficiently only via conjugative mobilization (Kienesberger et al., 2007). MOBP conjugation functions expressed by E. coli[e.g. E. coli S17-1lpir (de Lorenzo and Timmis, 1994) harbouring RP4 transfer genes on its chromosome] work well for shuttle vector mobilization to C. fetus and other campylobacters as long as these carry a P-like nic site for conjugative DNA processing (Pansegrau and Lanka, 1991; Francia et al., 2004) (Fig. 1). The type strains C. fetus ssp. venerealis ATCC 19438 and C. fetus ssp. fetus ATCC 27374 take up DNA readily, but C. fetus field isolates are somewhat harder to manipulate genetically. Nonetheless, only one of eight C. fetus field isolates, C. fetus ssp. venerealis strain 4111/108 (Hum et al., 1997), proved completely resistant to DNA uptake and plasmid vector maintenance thus far in our experiments. This strain already carries at least three natural plasmids including the original cryptic plasmid pCFV108, thus the limiting factor in this case may be stable maintenance or physiological stress of the host cell due to the high plasmid load. Little is known concerning naturally occurring plasmids in C. fetus. We surveyed the plasmid profiles of 34 C. fetus isolates. From 17 C. fetus ssp. fetus isolates four carried large (> 25 kb) plasmids and one small plasmid. Among the C. fetus ssp. venerealis isolates 15 of 17 harbour large plasmids and another three were found to carry a small plasmid. The presence of large plasmid genomes does not generally limit shuttle vector uptake.

Over 90% of all the C. fetus ssp. venerealis strains tested thus far (n = 67) harbour genes carried by a subspecies-specific genomic island on the chromosome which encode a bacterial T4SS (Gorkiewicz et al., 2010). The T4SS of C. fetus ssp. venerealis exhibits the most apparent synteny and homology with the resistance plasmids pCC31 of C. coli and pTet of C. jejuni (Batchelor et al., 2004; Friis et al., 2007). As described in the previous section, this T4SS supports intra- and interspecies mobilization of plasmids based on pIP1455 (S. Kienesberger, G. Gorkiewicz, A. Fauster and E.L. Zechner, unpublished) and is therefore useful for disseminating plasmids from C. fetus ssp. venerealis donor strains to other campylobacters and E. coli recipients. On the other hand, in some experiments, plasmid spread from a C. fetus ssp. venerealis strain to other (plasmid free) strains may be undesirable. In such cases, pCFV108-derived vectors are preferable as these are not mobilized by the C. fetus ssp. venerealis T4SS at detectable frequencies.

Plasmid DNA isolation from C. fetus is typically inefficient resulting in low yields and frequent nuclease degradation. Verification that a shuttle vector is maintained extrachromosomally in a C. fetus transconjugant is most efficient using a plasmid rescue strategy. To this end, E. coli cells are transformed with DNA preparations obtained from the putative C. fetus transconjugants. The emergence of E. coli transformants and subsequent plasmid isolation from the surrogate host proves the plasmid's extrachromosomal maintenance in C. fetus. Once confirmed, routine checks for plasmid maintenance in C. fetus are possible via positive selection or PCR amplification of plasmid genes. Spontaneous mutations to antibiotic resistance in C. fetus colonies occur very rarely. Moreover, we have never observed that shuttle vectors become integrated in the chromosome.

Gene expression

Unlike C. jejuni and C. coli, which tolerate exogenous promoters derived from non-related bacterial species (e.g. E. coli), C. fetus shows a higher stringency and efficient gene expression depends on the presence of a C. fetus-specific promoter. Until recently, the sapA promoter, which is present on the chromosomes of both subspecies, was the only characterized promoter known to be active in C. fetus (Dworkin et al., 1997; Tu et al., 2003). Two important characteristics of this promoter limit its use as an efficient genetic tool. First, gene-specific inactivation using a suicide vector that depends on the sapA promoter is subject to a high frequency of integration at alternative sites (see below). Second, the activity of the sapA promoter is temperature dependent. The optimal temperature appears to be around 37°C. Low gene expression was observed at 32°C (S. Kienesberger, G. Gorkiewicz, A. Fauster and E.L. Zechner, unpublished).

Options for controlled gene expression in C. fetus were improved by a recent screening for promoter fragments active in C. fetus ssp. venerealis under laboratory conditions. The 5′ regulatory regions of putative housekeeping genes (Dingle et al., 2001) predicted to support constitutive expression (gatC, rpsJ, glnA, gltA, gyrA) were identified on the C. fetus ssp. fetus genome sequence and test constructions for promoter activity were prepared by exchange of the sapA promoter from pRYVL1 (Fig. 1). The putative regulatory regions were amplified via PCR and introduced upstream of a aphA-3 gene from the C. coli plasmid pIP1433 (Trieu-Cuot et al., 1985). aphA-3 encodes 3′-amino-glycoside phosphotransferase, thus expression of this reporter confers kanamycin resistance. These recombinant plasmids were introduced into C. fetus ssp. venerealis and promoter activity was verified by antibiotic selection. The availability of alternative promoters provides us with a larger range of tractable conditions for gene expression and mutational analysis as described below. The temperature dependence of the sapA promoter provides an option for controlled gene expression. By contrast, the temperature independence of the gatC promoter is compatible with complementation studies performed at lower temperatures (S. Kienesberger, G. Gorkiewicz, A. Fauster and E.L. Zechner, unpublished). Phenotypic expression of resistance or molecular reporter genes in C. fetus has been demonstrated using aphA-3, the chloramphenicol acetyltransferase (cat) gene obtained from the C. coli plasmid pNR9589 (Wang and Taylor, 1990), the tetracycline resistance (tetO) gene originating from the C. jejuni plasmid pUA466 (Manavathu et al., 1988), and gfp (Miller et al., 2000; Kienesberger et al., 2007).

Mutational analyses

Molecular genetics approaches require tractable general and site-specific gene inactivation. Suitable strategies based on transposon mutagenesis and homologous recombination were developed for C. jejuni and C. coli (Labigne-Roussel et al., 1988; Yao et al., 1993; Golden et al., 2000; Colegio et al., 2001; Karlyshev and Wren, 2005), but are much less advanced in C. fetus applications. The current lack of tools for transposition continues to be a disadvantage. On the other hand, sequence-specific gene disruptions are now more readily obtained via recombination. Campylobacter fetus supports recA-mediated homologous recombination as well as recA-independent mechanisms (Ray et al., 2000). A facile approach for recombinant engineering of C. fetus ssp. fetus (Dworkin and Blaser, 1997) and C. fetus ssp. venerealis strains (Gorkiewicz et al., 2010) replaces the gene of interest with a selectable phenotypic marker via flanking homologous sequences. The targeting DNA for gene insertion is delivered conjugatively to C. fetus via a suicide plasmid not proficient for replication. Although 400 bp of homologous DNA on each side of the selectable marker can be sufficient for targeted gene insertion, the frequency of obtaining the desired gene disruption is enhanced substantially when the length of each homologous flank is extended to 1 kb. The selectable gene cassette, e.g. antibiotic resistance genes aphA or tetO, requires a C. fetus promoter. Constitutively expressed examples include rpsJ or gatC.

Application of cassette-specific PCR primers in combination with chromosome sequence outside of the targeting DNA is sufficient to verify the specificity of the gene disruption. Southern analyses of chromosomal DNA obtained from mutants routinely indicate single cassette insertions in our experiments. We have noted a pronounced strain variation in the efficiency of mutagenesis of C. fetus. In strains with a high frequency of site-specific insertions, e.g. C. fetus ssp. venerealis 84-112, complementation of the gene defect in trans is sometimes hard to achieve. Further analysis revealed that in these cases, wild-type levels of gene function are not obtained because the complementing gene on the vector and the chromosome undergo recombination ultimately disrupting expression. Thus for efficiently recombinogenic strains, limiting the length of the experiment worked best for effective complementation. A promising alternative for constitutive expression may be integration of the complementation cassette in a non-essential chromosomal gene, as shown previously for C. jejuni (Watson et al., 2007).

In vitro virulence assays

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

The biology of C. fetus infection is poorly defined. Molecular studies analysing Campylobacter–host interactions have focused predominantly on the species C. jejuni as this organism is the main cause of bacterial diarrhoea worldwide (Allos, 2001). No evidence is available to indicate whether C. fetus employs similar virulence strategies. In addition to colonizing mucosal tissues, which leads to enteritis and genital tract infections, both subspecies cause invasive extraintestinal infections and bacteraemia (Blaser et al., 2008). The molecular determinants underlying the difference in host and tissue preference of C. fetus in relation to the mainly ‘enteric’C. jejuni are not known. General features like the spiral morphology and the pronounced corkscrew-like motion are typical for all Campylobacters and prerequisites for the effective colonization of mucous membranes. These attributes have been directly correlated to gut colonization potential and severity of disease (Nachamkin et al., 1993; Yao et al., 1994; Chang and Miller, 2006; Malik-Kale et al., 2007). Mucosal infection also requires motility for the organism to gain access to exposed host cells (e.g. endometrium).

Epithelial cell attachment and invasion are virulence traits employed by several pathogens including Campylobacter. Several lines of evidence demonstrate that C. jejuni invades intestinal epithelial cells including histological examinations of intestinal biopsies from patients with enteritis (van Spreeuwel et al., 1985), animal models (Newell and Pearson, 1984; Babakhani et al., 1993; Russell et al., 1993; Yao et al., 1997) and in vitro experiments with cultured human intestinal epithelial cells (De Melo et al., 1989; Konkel and Joens, 1989; Oelschlaeger et al., 1993). According to current understanding, C. jejuni invades nonphagocytic intestinal epithelial cells via a microtubule and caveolae-dependent process, persists in the so-called Campylobacter-containing vacuole (Watson and Galan, 2008) and is later found in a close association with the Golgi apparatus. Several molecular determinants involved in adhesion and invasion have been identified so far (Hu and Kopecko, 2008; Larson et al., 2008). Among them a unique fibronectin-dependent attachment to the basolateral surface of epithelial cells via the CadF protein have been described for C. jejuni (Konkel et al., 2000; Kopecko et al., 2001). Mutagenesis applied to hyper-invasive clinical isolates offer a promising strategy to understand mechanisms contributing to invasion. The heightened activity in such isolates provide a wider range to detect reduced phenotypes and thus identify larger gene sets contributing to this activity (Javed et al., 2010).

A sheep model of C. fetus infection investigating ovine abortion was used to establish the role of the S-layer in pathogenesis (Grogono-Thomas et al., 2000; 2003; Tu et al., 2005). Although the C. fetus S-layer is essential for establishment and persistence of a systemic infection, it was clearly not the contributing factor of the feto-pathogenic effects resulting in abortion (Grogono-Thomas et al., 2000). As sap expression is shared by both subspecies, the divergent nature of the virulence attributes of both subspecies remains unknown. A C. fetus– SCID mouse model of chronic gastric infection was also reported, wherein chronic atrophic gastritis develops with a marked inflammatory response mimicking chronic gastritis caused by H. pylori (Young et al., 2000). Strikingly, no evidence of physical contact between bacteria and host, nor direct bacterial invasion of epithelial cells was observed microscopically in this study.

In vitro systems that adequately model the niche preferences of C. fetus are lacking. Fortunately, tractable cell culture-based approaches are emerging to support an initial investigation of host–pathogen interactions and analysis of the molecular determinants involved. Campylobacter fetus ssp. fetus adheres, invades and replicates within the epithelial cell line Int407 (Graham, 2002). Moreover, fibronectin was shown to enhance C. fetus interaction with extracellular matrix components and Int407 cells (Graham et al., 2008). The two sequenced C. fetus genomes carry homologues to C. jejuni cadF (G. Gorkiewicz and E. Zechner, unpublished data), thus an adherence mechanism similar to C. jejuni may represent a shared virulence attribute. Current efforts with C. fetus focus on assay development relying on well-documented C. jejuni properties and reference strains. Subsequent extension to less well-characterized endothelial and placental cells of human and bovine origin will be important to more closely model natural niche conditions for C. fetus. In the section below we summarize progress made thus far in studying the shared and divergent virulence properties of C. fetus subspecies manifest in vitro in combination with a functional genomics approach.

Mammalian cell invasion

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

Commonly used gentamicin protection assays (Elsinghorst, 1994) were performed using semi-confluent or confluent monolayers of mammalian epithelial cell lines. Thus far all lines we have tested (Caco-2, Int407, HeLa, CHO-K1, ACH-3P) were invaded by C. fetus in vitro with human colonic Caco-2 cells reproducibly supporting the highest level of invasion (Gorkiewicz et al., 2010). Mammalian cell lines are cultivated in vitro and Campylobacter are introduced at a moi of 100–500. Over a time-course up to 24 h, the maximum of cell invasion occurs within the first 2 h of co-cultivation. The subsequent gentamicin treatment (400 µg ml−1) is necessary for at least 2 h to kill all extracellular bacteria. Bacteria more efficiently invade semi-confluent monolayers than confluent monolayers. Invasion is also strain dependent and clinical isolates are generally more invasive than the C. fetus type strains (100-fold) (Fig. 2). The sequenced strains C. fetus ssp. fetus 82-40 and C. fetus ssp. venerealis 84-112 achieve invasion levels of about one bacterium per Caco-2 cell after 2 h of co-cultivation, comparable to that of C. jejuni (Fig. 2). Additionally, both subspecies invade the human chorioncarcinoma cell line ACH-3P (Hiden et al., 2007).

image

Figure 2. Quantitative comparison of intracellular Campylobacter when Caco-2 cells or the human placental cell line ACH-3P were cultivated on a typical plastic substratum (PS) or on transwell filters (TW). A. Values for invasion per Caco-2 cell reflect the number of bacteria surviving 2 h of 400 µg ml−1 gentamicin treatment relative to the number of exposed host cells after 2 h invasion time. Intracellular bacteria/Caco-2 cell: C. fetus ssp. venerealis ATCC19438 PS: 0004 (±0001); TW 0001 (±0001); C. fetus ssp. venerealis 84-112: PS 1,80 (±0,20); TW 0,20 (±0,07); C. fetus ssp. fetus 82-40: PS 3,23 (±0,17); TW 0,38 (±0,10); C. jejuni B02/55: PS 1,34 (±0,14); TW 0,07 (±0,03); **P < 0.005; B. Values for invasion per ACH-3P cell reflect the number of bacteria surviving 2 h of 400 µg ml−1 gentamicin treatment relative to the number of exposed host cells after 3 h invasion time; C. fetus ssp. fetus 82-40: PS 0,27 (±0,05); TW 0,10 (±0,03); C. fetus ssp. venerealis 84-112 PS 0,04 (±0,01); TW 0,01 (±0,00); C. jejuni DSM 4688: PS 0,14 (±0,01); TW 0,17 (±0,05); *P < 0.05.

Download figure to PowerPoint

The molecular mechanisms involved in C. fetus host cell invasion are largely unknown. However, analyses of the bacterial invasion phenotype are readily combined with mutational inactivation of putative virulence genes. The gentamicin protection assay can be easily performed and its application will facilitate a functional characterization of C. fetus virulence attributes similarly to previous investigations of host–pathogen interaction in other systems. For example disruption of genes carried by a C. fetus pathogenicity island and complementation of the mutant strain in trans was reported recently. In this study mutation of virD4, encoding an essential component of a bacterial Type IV secretion apparatus reduced invasiveness of strain C. fetus ssp. venerealis 84-112 by 50% compared with that of the wild-type parent strain (Gorkiewicz et al., 2010). The extent of attenuation due to the virD4 disruption is in line with invasion phenotypes observed in a mutational analysis of the pVir encoded T4SS components of C. jejuni (Bacon et al., 2000; 2002). By contrast mutational inactivation of the cdtB gene, encoding the active subunit of the cytolethal distending toxin, did not result in an attenuated invasion phenotype (Gorkiewicz et al., 2010).

Differential immunofluorescence staining

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

Intracellular C. fetus can be visualized using differential immunofluorescence staining (Fig. 3) as previously established for other pathogens (Elsinghorst, 1994; Dehio et al., 1997; Pentecost et al., 2006). A standard staining procedure for labelling intracellular bacteria (Srivastava and Isberg, 2002) was adapted for C. fetus using monoclonal anti-C. fetus serotype A antibodies (Brooks et al., 2002) and Alexa Dye-conjugated secondary antibodies (Invitrogen). Campylobacter fetus-infected Caco-2 cells were treated sequentially with gentamicin, then with primary and secondary antibodies. To distinguish intracellular from extracellular bacteria the host cells were then permeabilized with methanol followed by restaining with the same primary but a different secondary antibody. Microscopy readily localizes intracellular bacteria within the infected mammalian cells when clinical or field isolates of either C. fetus subspecies are investigated. By contrast the type strains C. fetus ssp. venerealis ATCC 19438 and C. fetus ssp. fetus ATCC 27374 are non-invasive and serve as negative controls for intracellular visualisation of bacteria. An example of Caco-2 cells infected with the clinical isolate C. fetus ssp. fetus 82-40 is shown in Fig. 3. Intracellular bacteria are stained with red only. Solely green or yellow (red plus green) dually labelled bacteria (circle) identify cells in extracellular locations. This immunofluorescence approach combined with confocal microscopy is at an early stage yet it is proving informative for visualizing C. fetus–host cell interactions. The development of techniques including differential staining of cell compartments or structures will offer clearer, more detailed localization data for bacteria within infected cells (Watson and Galan, 2008). Moreover, the capacity to differentiate intracellular and extracellular bacteria is important to defining the phenotypes of mutants functionally deficient for host cell entry versus those defective in intracellular viability.

image

Figure 3. Confocal microscopic visualization of intracellular bacteria. Caco-2 cells were cultured to confluency in chamber slides or on coverslips placed in 12-well tissue culture dishes. Campylobacter fetus ssp. fetus 82-40 (Cff) were added at moi = 500 for 14 h, treated with gentamicin for 2 h, then washed and fixed with 3% paraformaldehyde. Extracellular Cff cells were then labelled with a monoclonal mouse anti-C. fetus serotype A antibody (42), followed by an Alexa-488 conjugated goat-anti-mouse-antibody (B, green channel). Eukaryotic cells were permeabilized with 100% methanol for 10 s and Cff was again labelled with the monoclonal mouse anti-C. fetus serotype A antibody followed by an Alexa-633-conjugated goat-anti-mouse antibody (C, red channel). Caco-2 nuclei were stained with DAPI (D, blue channel). In this differential immunostaining approach intracellular C. fetus appear solely red, whereas extracellular bacteria are doubly stained (red and green), the combination appears yellow when superimposed (E and F). A. Differential interference contrast. B–D. Green, red and blue channels respectively. E and F. Overlay of the green and red channels (E) and the green, red and blue channels (F). Intracellular bacteria localized in the vicinity of the nucleus (white arrow), putative bacterial subvasion (yellow arrowhead) and extracellular, doubly labelled bacteria (circles) are indicated (E, F). Scale bar, 10 µm. Negative controls were provided by the non invasive C. fetus ssp. venerealis ATCC 19438 and samples treated the same way, except for permeabilization, to confirm the integrity of the fixed cell membranes (not shown).

Download figure to PowerPoint

Bacterial migration: detection and quantification

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

In developing the intracellular imaging protocols we routinely observed foci of bacteria (Fig. 3, yellow arrowhead) appearing in the red channel, despite the fact that the location of these foci was actually extracellular in repeated experiments (verified by cross sectioning with the confocal microscope). This phenomenon revealed an unexpected proficiency of C. fetus for migration underneath the cell monolayer and raised the question of whether this ability is important for C. fetus virulence. Moreover, the observed migration was very likely to yield artificially high values for intracellular bacteria in conventional gentamicin protection assays. To quantitatively distinguish intracellular bacteria from those in the protected compartment underneath the mammalian monolayer we altered the cell culture substrate used in the cell invasion assays. To permit gentamicin penetration from both the apical and basal sides, transwell membrane inserts were used. Host cells were grown to confluence either in typical 24-well plastic tissue culture plates or on membranes (pore size 3 µm) inserted into such plates to allow application of gentamicin apically and basally to kill extracellular bacteria. The relative difference in surviving C. fetus as determined with standard culture dishes versus membrane inserts allows an assessment of the percentage of migrating cells. Remarkably we find clear evidence for gentamicin protection via bacterial migration not only for all the invasive C. fetus isolates tested thus far (n = 4) but also for the C. jejuni strain B02/55 (Fig. 2). Significantly higher numbers of bacteria (10–20-fold) survive gentamicin treatment when host cells were grown on a standard plastic substratum compared with the transwell system (Fig. 2). This clearly implies that artificially high numbers of bacteria are assigned an intracellular localization when standard gentamicin protection assays are applied to campylobacters. The migration underneath the host cells, also termed subvasion, has been observed with C. jejuni, which subsequently migrates to the basolateral cell side prior to cell invasion (Van alphen et al., 2008). Taken together it follows that studies using a polarized cell layer on appropriate transwell membrane inserts combined with microscopic techniques may provide mechanistic details concerning bacterial migration, attachment and invasion, which in turn will facilitate our understanding of C. fetus virulence.

Concluding remarks

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

Molecular microbiology has witnessed dramatic breakthroughs over the last decade in understanding the molecular basis of host interactions with bacterial pathogens. That in part is due to tremendous progress in imaging technologies applied to bacteria/host cell interactions (e.g. high-resolution fluorescence microscopy) and to advances in functional genomics as well as in the capacity to decipher complex gene regulatory networks. Research aims with Campylobacters remain at a comparatively early stage, but are certain to benefit widely from these rapid technical developments in the field, and intensified efforts with Campylobacters specifically.

The small-sized genomes of Campylobacter (about 1.5 Mb) are in a process of gene decay (Fouts et al., 2005) and nearly devoid of non-coding sequence, and thus represent a very attractive model for comparative genomic analyses. Moreover campylobacter genome sequences determined thus far reveal relatively little overlap with the virulence repertoire of other bacterial pathogens. An important prospective for the field therefore depends on an expanded database of genomic information to support intra- and inter-species comparisons among camplyobacters, as well as with other pathogens (e.g. CampyDB; Chaudhuri and Pallen, 2006). Those data provide the resources to support a detailed analysis of their pathogenic potential. Based on our current knowledge priorities within such surveys are genes contributing to motility, cell surface structures and systems capable of modifying these, gene sets involved in host cell invasion and intracellular survival, as well as metabolic systems important to growth in vitro and in human and animal hosts. Comparative analyses provide the rationale for mutagenesis of interesting candidate genes selected because of their conservation, their uniqueness, their genome context, or their probable acquisition through HGT. Conversely, the genomic data vastly facilitate interpretation of the results of random mutagenesis in studies of multifaceted phenotypes such as pathogen- host cell interactions.

The host and tissue tropism of C. fetus subspecies offers a unique opportunity to understand the molecular bases of habitat selection of bacterial pathogens and consequently to understand the different disease entities arising from this adaptation. Much is still to be learned about the phenotypic differences distinguishing the subspecies. The availability of the genome sequence of C. fetus ssp. venerealis 84-112 in conjunction with C. fetus ssp. fetus 82-40 reveals that the major genotypic difference consists of horizontally acquired DNA. The remaining core genomes are nearly identical, consistent with the early proposal that C. fetus ssp. fetus and C. fetus ssp. venerealis are genetically clonal, wherein C. fetus ssp. venerealis represents a bovine clone of C. fetus ssp. fetus (van Bergen et al., 2005). By contrast, C. fetus strains adapted to reptilian hosts appear to represent a more ancient clade (Dingle et al., 2010). Exploration of the genetic basis underlying gut mucosal tropism versus tropism to the genital mucosa is expected to rapidly advance using in-depth comparative genomic analyses of the two genomes. A logical extension of the genome comparison would pursue the potential for cross-complementation of C. fetus structures and functions. This strategy is feasible for mutated single genes as well as in linked gene sets or functional modules specific to a given subspecies. For example, the recently reported subspecies-specific pathogenicity island of C. fetus ssp. venerealis harbours multiple genes potentially involved in mucosal infection (Gorkiewicz et al., 2010).

To fully capitalize on the insights offered by the genomic comparison, an important immediate challenge for the field is the need to establish in vitro infection models reflecting C. fetus pathogenicity in vivo including an expansion into bovine cells of genital origin. A subsequent long-term goal must be to develop simple animal models of colonization and disease. Existing infection models in cattle and sheep are limiting in a number of practical ways. Successful adaptation of comparatively powerful systems such as C. elegans or rodent models would mark a true breakthrough towards a mechanistic understanding of C. fetus infection.

Acknowledgements

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References

We thank Martin Blaser for helpful comments and Brian Brooks for the generous gift of C. fetus monoclonal antibodies. Campylobacter fetus ssp. venerealis 84-112 was sequenced in cooperation with Christian Gülly, Center for Medical Research, Medical University of Graz. This work was supported by the Austrian Academy of Science's DOC scholarship, awarded to S.K. and by the Austrian FWF (P20479-B05 and P18607-B12).

References

  1. Top of page
  2. Summary
  3. Introduction
  4. Molecular genetics
  5. In vitro virulence assays
  6. Mammalian cell invasion
  7. Differential immunofluorescence staining
  8. Bacterial migration: detection and quantification
  9. Concluding remarks
  10. Acknowledgements
  11. References
  • Allos, B.M. (2001) Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 32: 12011206.
  • van Alphen, L.B., Bleumink-Pluym, N.M., Rochat, K.D., van Balkom, B.W., Wosten, M.M., and van Putten, J.P. (2008) Active migration into the subcellular space precedes Campylobacter jejuni invasion of epithelial cells. Cell Microbiol 10: 5366.
  • Babakhani, F.K., Bradley, G.A., and Joens, L.A. (1993) Newborn piglet model for campylobacteriosis. Infect Immun 61: 34663475.
  • Bacon, D.J., Alm, R.A., Burr, D.H., Hu, L., Kopecko, D.J., Ewing, C.P., et al. (2000) Involvement of a plasmid in virulence of Campylobacter jejuni 81-176. Infect Immun 68: 43844390.
  • Bacon, D.J., Alm, R.A., Hu, L., Hickey, T.E., Ewing, C.P., Batchelor, R.A., et al. (2002) DNA sequence and mutational analyses of the pVir plasmid of Campylobacter jejuni 81-176. Infect Immun 70: 62426250.
  • van Bergen, M.A., Dingle, K.E., Maiden, M.C., Newell, D.G., van der Graaf-Van Bloois, L., van Putten, J.P., and Wagenaar, J.A. (2005) Clonal nature of Campylobacter fetus as defined by multilocus sequence typing. J Clin Microbiol 43: 58885898.
  • Batchelor, R.A., Pearson, B.M., Friis, L.M., Guerry, P., and Wells, J.M. (2004) Nucleotide sequences and comparison of two large conjugative plasmids from different Campylobacter species. Microbiology 150: 35073517.
  • Blaser, M.J. (1998) Campylobacter fetus – emerging infection and model system for bacterial pathogenesis at mucosal surfaces. Clin Infect Dis 27: 256258.
  • Blaser, M.J., Newell, D.G., Thompson, S.A., and Zechner, E.L. (2008) Pathogenesis of Campylobacter fetus infections. In Campylobacter, Nachamkin, I., Szymanski, C.M., and Blaser, M.J. (eds). Washington, DC, USA: ASM Press, pp. 401428.
  • de Boer, P., Wagenaar, J.A., Achterberg, R.P., van Putten, J.P., Schouls, L.M., and Duim, B. (2002) Generation of Campylobacter jejuni genetic diversity in vivo. Mol Microbiol 44: 351359.
  • Boto, L. (2010) Horizontal gene transfer in evolution: facts and challenges. Proc Biol Sci 277: 819827.
  • Brooks, B.W., Robertson, R.H., Lutze-Wallace, C.L., and Pfahler, W. (2002) Monoclonal antibodies specific for Campylobacter fetus lipopolysaccharides. Vet Microbiol 87: 3749.
  • Chang, C., and Miller, J.F. (2006) Campylobacter jejuni colonization of mice with limited enteric flora. Infect Immun 74: 52615271.
  • Chaudhuri, R.R., and Pallen, M.J. (2006) xBASE, a collection of online databases for bacterial comparative genomics. Nucleic Acids Res 34: D335D337.
  • Christie, P.J., and Vogel, J.P. (2000) Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells. Trends Microbiol 8: 354360.
  • Colegio, O.R., Griffin, T.J., Grindley, N.D., and Galán, J.E. (2001) In vitro transposition system for efficient generation of random mutants of Campylobacter jejuni. J Bacteriol 183: 23842388.
  • De Melo, M.A., Gabbiani, G., and Pechere, J.C. (1989) Cellular events and intracellular survival of Campylobacter jejuni during infection of HEp-2 cells. Infect Immun 57: 22142222.
  • Dehio, C., Meyer, M., Berger, J., Schwarz, H., and Lanz, C. (1997) Interaction of Bartonella henselae with endothelial cells results in bacterial aggregation on the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate by a unique structure, the invasome. J Cell Sci 110: 21412154.
  • Dingle, K.E., Colles, F.M., Wareing, D.R., Ure, R., Fox, A.J., Bolton, F.E., et al. (2001) Multilocus sequence typing system for Campylobacter jejuni. J Clin Microbiol 39: 1423.
  • Dingle, K.E., Blaser, M.J., Tu, Z.C., Pruckler, J., Fitzgerald, C., van Bergen, M.A., et al. (2010) Genetic relationships among reptile and mammalian Campylobacter fetus by Multilocus Sequence Typing. J Clin Microbiol 48: 977980.
  • Dworkin, J., and Blaser, M.J. (1997) Nested DNA inversion as a paradigm of programmed gene rearrangement. Proc Natl Acad Sci USA 94: 985990.
  • Dworkin, J., Shedd, O.L., and Blaser, M.J. (1997) Nested DNA inversion of Campylobacter fetus S-layer genes is recA dependent. J Bacteriol 179: 75237529.
  • Elsinghorst, E.A. (1994) Measurement of invasion by gentamicin resistance. Methods Enzymol 236: 405420.
  • Eppinger, M., Baar, C., Raddatz, G., Huson, D.H., and Schuster, S.C. (2004) Comparative analysis of four Campylobacterales. Nat Rev Microbiol 2: 872885.
  • Fouts, D.E., Mongodin, E.F., Mandrell, R.E., Miller, W.G., Rasko, D.A., Ravel, J., et al. (2005) Major structural differences and novel potential virulence mechanisms from the genomes of multiple Campylobacter species. PLoS Biol 3: 7285.
  • Francia, M.V., Varsaki, A., Garcillán-Barcia, M.P., Latorre, A., Drainas, C., and Cruz, F. (2004) A classification scheme for mobilization regions of bacterial plasmids. FEMS Microbiol Rev 28: 79100.
  • Friis, L.M., Pin, C., Taylor, D.E., Pearson, B.M., and Wells, J.M. (2007) A role for the tet(O) plasmid in maintaining Campylobacter plasticity. Plasmid 57: 1828.
  • Gogarten, J.P., Doolittle, W.F., and Lawrence, J.G. (2002) Prokaryotic evolution in light of gene transfer. Mol Biol Evol 19: 22262238.
  • Golden, N.J., Camilli, A., and Acheson, D.W. (2000) Random transposon mutagenesis of Campylobacter jejuni. Infect Immun 68: 54505453.
  • Gorkiewicz, G., Kienesberger, S., Schober, C., Scheicher, S.R., Gully, C., Zechner, R., and Zechner, E.L. (2010) A genomic island defines subspecies-specific virulence features of the host-adapted pathogen Campylobacter fetus subsp. venerealis. J Bacteriol 192: 502517.
  • Graham, L.L. (2002) Campylobacter fetus adheres to and enters INT 407 cells. Can J Microbiol 48: 9951007.
  • Graham, L.L., Friel, T., and Woodman, R.L. (2008) Fibronectin enhances Campylobacter fetus interaction with extracellular matrix components and INT 407 cells. Can J Microbiol 54: 3747.
  • Grogono-Thomas, R., Dworkin, J., Blaser, M.J., and Newell, D.G. (2000) Roles of the surface layer proteins of Campylobacter fetus subsp. fetus in ovine abortion. Infect Immun 68: 16871691.
  • Grogono-Thomas, R., Blaser, M.J., Ahmadi, M., and Newell, D.G. (2003) Role of S-layer protein antigenic diversity in the immune responses of sheep experimentally challenged with Campylobacter fetus subsp. fetus. Infect Immun 71: 147154.
  • Hacker, J., Blum-Oehler, G., Muhldorfer, I., and Tschape, H. (1997) Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 23: 10891097.
  • Hiden, U., Wadsack, C., Prutsch, N., Gauster, M., Weiss, U., Frank, H.G., et al. (2007) The first trimester human trophoblast cell line ACH-3P: a novel tool to study autocrine/paracrine regulatory loops of human trophoblast subpopulations – TNF-alpha stimulates MMP15 expression. BMC Dev Biol 7: 137.
  • Horvath, P., and Barrangou, R. (2010) CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167170.
  • Hu, L., and Kopecko, D.J. (2000) Interactions of Campylobacter with eukaryotic cells: Gut luminal colonization and mucosal invasion mechanisms. In Campylobacter, Nachamkin, I., and Blaser, M.J. (eds). Washington, DC, USA: ASM Press, pp. 191215.
  • Hu, L., and Kopecko, D.J. (2008) Human Host Cell Entry. Campylobacter, Nachamkin, I., Szymanski, C.M., and Blaser, M.J. (eds). Washington, DC, USA: ASM Press, pp. 297313.
  • Hum, S., Quinn, K., Brunner, J., and On, S.L. (1997) Evaluation of a PCR assay for identification and differentiation of Campylobacter fetus subspecies. Aust Vet J 75: 827831.
  • Javed, M.A., Grant, A.J., Bagnall, M.C., Maskell, D.J., Newell, D.G., and Manning, G. (2010) Transposon mutagenesis in a hyper-invasive clinical isolate of Campylobacter jejuni reveals a number of genes with potential roles in invasion. Microbiology (in press).
  • Juhas, M., van der Meer, J.R., Gaillard, M., Harding, R.M., Hood, D.W., and Crook, D.W. (2009) Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol Rev 33: 376393.
  • Karlyshev, A.V., and Wren, B.W. (2005) Development and application of an insertional system for gene delivery and expression in Campylobacter jejuni. Appl Environ Microbiol 71: 40044013.
  • Kienesberger, S., Gorkiewicz, G., Joainig, M.M., Scheicher, S.R., Leitner, E., and Zechner, E.L. (2007) Development of experimental genetic tools for Campylobacter fetus. Appl Environ Microbiol 73: 46194630.
  • Konkel, M.E., and Joens, L.A. (1989) Adhesion to and invasion of HEp-2 cells by Campylobacter spp. Infect Immun 57: 29842990.
  • Konkel, M.E., Joens, L.A., and Mixter, P.F. (2000) Molecular characterization of Campylobacter jejuni virulence determinants. In Campylobacter. Nachamkin, I., and Blaser, M.J. (eds). Washington, DC, USA: American Society for Microbiology, pp. 217240.
  • Koonin, E.V., and Wolf, Y.I. (2008) Genomics of bacteria and archaea: the emerging dynamic view of the prokaryotic world. Nucleic Acids Res 36: 66886719.
  • Kopecko, D.J., Hu, L., and Zaal, K.J. (2001) Campylobacter jejuni – microtubule-dependent invasion. Trends Microbiol 9: 389396.
  • Labigne-Roussel, A., Courcoux, P., and Tompkins, L. (1988) Gene disruption and replacement as a feasible approach for mutagenesis of Campylobacter jejuni. J Bacteriol 170: 17041708.
  • Lambert, T., Gerbaud, G., Trieu-Cuot, P., and Courvalin, P. (1985) Structural relationship between the genes encoding 3′-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci. Ann Inst Pasteur Microbiol 136B: 135150.
  • Larson, C.L., Christensen, J.E., Pacheco, S.A., Minnich, S.A., and Konkel, M.E. (2008) Campylobacter jejuni secretes proteins via the flagellar type III secretion system that contribute to host cell invasion and gastroenteritis. In Campylobacter, Nachamkin, I., Szymanski, C.M., and Blaser, M.J. (eds). Washington, DC, USA: ASM Press, pp. 315332.
  • Lisitsyn, N., and Wigler, M. (1993) Cloning the differences between two complex genomes. Science 259: 946951.
  • de Lorenzo, V., and Timmis, K.N. (1994) Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol 235: 386405.
  • Maiden, M.C., Bygraves, J.A., Feil, E., Morelli, G., Russell, J.E., Urwin, R., et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 95: 31403145.
  • Malik-Kale, P., Raphael, B.H., Parker, C.T., Joens, L.A., Klena, J.D., Quinones, B., et al. (2007) Characterization of genetically matched isolates of Campylobacter jejuni reveals that mutations in genes involved in flagellar biosynthesis alter the organism's virulence potential. Appl Environ Microbiol 73: 31233136.
  • Manavathu, E.K., Hiratsuka, K., and Taylor, D.E. (1988) Nucleotide sequence analysis and expression of a tetracycline-resistance gene from Campylobacter jejuni. Gene 62: 1726.
  • Marraffini, L.A., and Sontheimer, E.J. (2008) CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322: 18431845.
  • Miller, W.G. (2008) Comparative genomics of Campylobacter species other than Campylobacter jejuni. In Campylobacter, Nachamkin, I., Szymanski, C.M., and Blaser, M.J. (eds). Washington, DC, USA: ASM Press, pp. 7395.
  • Miller, W.G., Bates, A.H., Horn, S.T., Brandl, M.T., Wachtel, M.R., and Mandrell, R.E. (2000) Detection on surfaces and in Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids. Appl Environ Microbiol 66: 54265436.
  • Nachamkin, I., Yang, X.H., and Stern, N.J. (1993) Role of Campylobacter jejuni flagella as colonization factors for three-day-old chicks: analysis with flagellar mutants. Appl Environ Microbiol 59: 12691273.
  • Newell, D.G., and Pearson, A. (1984) The invasion of epithelial cell lines and the intestinal epithelium of infant mice by Campylobacter jejuni/coli. J Diarrhoeal Dis Res 2: 1926.
  • Oelschlaeger, T.A., Guerry, P., and Kopecko, D.J. (1993) Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc Natl Acad Sci USA 90: 68846888.
  • Pansegrau, W., and Lanka, E. (1991) Common sequence motifs in DNA relaxases and nick regions from a variety of DNA transfer systems. Nucleic Acids Res 19: 3455.
  • Parkhill, J., Wren, B.W., Mungall, K., Ketley, J.M., Churcher, C., Basham, D., et al. (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665668.
  • Pearson, B.M., Gaskin, D.J., Segers, R.P., Wells, J.M., Nuijten, P.J., and van Vliet, A.H. (2007) The complete genome sequence of Campylobacter jejuni strain 81116 (NCTC11828). J Bacteriol 189: 84028403.
  • Pentecost, M., Otto, G., Theriot, J.A., and Amieva, M.R. (2006) Listeria monocytogenes invades the epithelial junctions at sites of cell extrusion. PLoS Pathog 2: 2940.
  • Poly, F., Read, T., Tribble, D.R., Baqar, S., Lorenzo, M., and Guerry, P. (2007) Genome sequence of a clinical isolate of Campylobacter jejuni from Thailand. Infect Immun 75: 34253433.
  • Ray, K.C., Tu, Z.C., Grogono-Thomas, R., Newell, D.G., Thompson, S.A., and Blaser, M.J. (2000) Campylobacter fetus sap inversion occurs in the absence of RecA function. Infect Immun 68: 56635667.
  • Russell, R.G., O'Donnoghue, M., Blake, D.C., Jr, Zulty, J., and DeTolla, L.J. (1993) Early colonic damage and invasion of Campylobacter jejuni in experimentally challenged infant Macaca mulatta. J Infect Dis 168: 210215.
  • Salama, S.M., Garcia, M.M., and Taylor, D.E. (1992) Differentiation of the subspecies of Campylobacter fetus by genomic sizing. Int J Syst Bacteriol 42: 446450.
  • Skirrow, M.B., and Blaser, M.J. (2000) Clinical aspects of Campylobacter infections. In Campylobacter, Nachamkin, I., and Blaser, M.J. (eds). Washington, DC, USA: ASM Press, pp. 6988.
  • Srivastava, A., and Isberg, R.R. (2002) Measurement of bacterial uptake by cultured cells. In Molecular and Cellular Microbiology (Methods in Microbiology), Vol. 31. Sansonetti, P., and Zychlinsky, A. (eds). London, UK: Academic Press, pp. 179188.
  • Thompson, S.A., and Blaser, M.J. (2000) Pathogenesis of Campylobacter fetus infections. In Campylobacter, Nachamkin, I., and Blaser, M.J. (eds). Washington, DC, USA: ASM Press, pp. 321347.
  • Trieu-Cuot, P., Gerbaud, G., Lambert, T., and Courvalin, P. (1985) In vivo transfer of genetic information between gram-positive and gram-negative bacteria. EMBO J 4: 35833587.
  • Tu, Z.C., Wassenaar, T.M., Thompson, S.A., and Blaser, M.J. (2003) Structure and genotypic plasticity of the Campylobacter fetus sap locus. Mol Microbiol 48: 685698.
  • Tu, Z.C., Gaudreau, C., and Blaser, M.J. (2005) Mechanisms underlying Campylobacter fetus pathogenesis in humans: surface-layer protein variation in relapsing infections. J Infect Dis 191: 20822089.
  • van Spreeuwel, J.P., Duursma, G.C., Meijer, C.J., Bax, R., Rosekrans, P.C., and Lindeman, J. (1985) Campylobacter colitis: histological immunohistochemical and ultrastructural findings. Gut 26: 945951.
  • Wang, Y., and Taylor, D.E. (1990) Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene 94: 2328.
  • Waterman, S.R., Hackett, J., and Manning, P.A. (1993) Isolation of a restriction-less mutant and development of a shuttle vector for the genetic analysis of Campylobacter hyointestinalis. Gene 125: 1924.
  • Watson, R.O., and Galan, J.E. (2008) Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathog 4: e14.
  • Watson, R.O., Novik, V., Hofreuter, D., Lara-Tejero, M., and Galan, J.E. (2007) A MyD88-deficient mouse model reveals a role for Nramp1 in Campylobacter jejuni infection. Infect Immun 75: 19942003.
  • Wiesner, R.S., Hendrixson, D.R., and DiRita, V.J. (2003) Natural transformation of Campylobacter jejuni requires components of a type II secretion system. J Bacteriol 185: 54085418.
  • Yao, R., Alm, R.A., Trust, T.J., and Guerry, P. (1993) Construction of new Campylobacter cloning vectors and a new mutational cat cassette. Gene 130: 127130.
  • Yao, R., Burr, D.H., Doig, P., Trust, T.J., Niu, H., and Guerry, P. (1994) Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol Microbiol 14: 883893.
  • Yao, R., Burr, D.H., and Guerry, P. (1997) CheY-mediated modulation of Campylobacter jejuni virulence. Mol Microbiol 23: 10211031.
  • Young, V.B., Dangler, C.A., Fox, J.G., and Schauer, D.B. (2000) Chronic atrophic gastritis in SCID mice experimentally infected with Campylobacter fetus. Infect Immun 68: 21102118.